Farzan Nima

CIK 00018082962 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001808296

Recent Transactions

17 trades

Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2025-06-04+10,500→ 10,500 total
Award
Keros Therapeutics, Inc.$KROS
Common Stock
2025-06-04+5,250→ 5,250 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2024-05-30+10,000→ 10,000 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−400,000→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Common Stock
2024-04-03−2,186→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−275,000→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−437,413→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−750,000→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−1,281,642→ 0 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2023-06-06+10,000→ 10,000 total
Award
Kinnate Biopharma Inc.
Employee Stock Option (right to buy)
2023-02-10+750,000→ 215,000 total
Award
Kinnate Biopharma Inc.
Employee Stock Option (right to buy)
2023-02-10+750,000→ 750,000 total
Award
Keros Therapeutics, Inc.$KROS
Stock Options (right to buy)
2022-06-01+8,293→ 8,293 total
Award
Kinnate Biopharma Inc.
Employee Stock Option (right to buy)
2022-02-11+400,000→ 400,000 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2021-06-01+8,293→ 8,293 total
Award
Kinnate Biopharma Inc.
Employee stock option (right to buy)
2021-02-12+275,000→ 275,000 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2020-05-29+8,500→ 8,500 total

Companies

Recent Filings

Address

C/O KEROS THERAPEUTICS, INC. 1050 WALTHAM STREET, SUITE 302

LEXINGTON, MA, 02421

View on SEC.gov